Abstract:Previous studies suggested that the thrombospondin-1/transforming growth factor-β1 (TSP-1/TGF-β1) pathway might be critical in synaptogenesis during development and that the purinergic P2 receptor family could regulate synaptogenesis by modulating TSP-1 signaling. However, it is unclear whether this pathway plays a role in synaptogenesis during epileptic progression. This study was designed to investigate this question by analyzing the dynamic changes and effects of TSP-1 levels on the density of synaptic markers that are related to epileptic seizure activity. In addition, we evaluated whether P2-type receptors could regulate these effects. We generated a rat seizure model via amygdala kindling and inhibited TSP-1 activity using small interfering RNA (siRNA) interference and pharmacological inhibition. We treated the rats with antagonists of P2 or P2Y receptors, pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic (PPADS) or Reactive Blue 2. Following this, we quantified TSP-1 and TGF-β1 immunoreactivity (IR), the density of synaptic markers, and seizure activity. There were significantly more synapses/excitatory synapses in several brain regions, such as the hippocampus, which were associated with progressing epileptic discharges after kindling. These were associated with increased TSP-1 and TGF-β1-IR. Genetic or pharmacologic inhibition of TSP-1 significantly reduced the density of synaptic/excitatory synaptic markers and inhibited the generalization of focal epilepsy. The administration of PPADS or Reactive Blue 2 attenuated the increase in TSP-1-IR and the increase in the density of synaptic markers that follows kindling and abolished most of the epileptic seizure activity. Altogether, our results indicate that the TSP-1/TGF-β1 pathway and its regulation by P2, particularly P2Y-type receptors, may be a critical promoter of synaptogenesis during the progression of epilepsy. Therefore, components of this pathway may be targets for novel antiepileptic drug development.

NMDA receptor in the pathogenesis of epilepsy

Roles of N-Methyl-D-Aspartate Receptors (nmdars) in Epilepsy.

Differential Roles of NR2A- and NR2B-containing NMDA Receptors in Activity-Dependent Brain-Derived Neurotrophic Factor Gene Regulation and Limbic Epileptogenesis.

Decreased Synapse‐associated Proteins Are Associated with the Onset of Epileptic Memory Impairment in Endothelial CDK5‐deficient Mice

NMDA receptor function is enhanced in the cerebral cortex and hippocampus of genetically epilepsy-prone rat

NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus

A Purinergic P2 Receptor Family-Mediated Increase in Thrombospondin-1 Bolsters Synaptic Density and Epileptic Seizure Activity in the Amygdala-Kindling Rat Model

Audiogenic Seizure Can Alter N-methyl-D-aspartate Receptor Subunits NR1, NR2A, NR2B Immunoreactivity in Epilepsy-Prone Rat Brain

Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy

The Function Change of NMDA Receptor in P77PMC Rat Brain after Audiogenic Seizure

Changes in Synaptic and Extrasynaptic N-Methyl-D-Aspartate Receptor-Mediated Currents at Early-Stage Epileptogenesis in Adult Mice

Down regulation of NMDA receptor subunits NR2A and NR2B mRNA e xpression after audiogenic seizure in epilepsy-prone rat brain

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility

Functional Roles of Synaptic and Extrasynaptic NMDA Receptors in Physiological and Pathological Neuronal Activities.

NMDA Receptors in Nervous System Diseases

Voltage-Dependent Calcium Channels, Calcium Binding Proteins, and Their Interaction in the Pathological Process of Epilepsy

Nmdar1 Mrna Expression Increased after Seizure in Genetically Epilepsy-Prone Rat.

The Role of Glutamate Receptors in Epilepsy

NMDA receptors in nervous system diseases.

Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents

Regulation of NMDA receptor trafficking and gating by activity-dependent CaMKIIα phosphorylation of the GluN2A subunit